Cue Biopharma ($CUE) Insider Trading & Smart Money Activity
Cue Biopharma, Inc. ($CUE) has 3 insider trades on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($389.30K), net -$389.30K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$389.30K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
CUE insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 3 · $389.30K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CUE insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Ray SumitaChief Legal Compliance Officer | Sell (Open-market sale) | 1.84K sh | $51.72K | Read | ||||||
| Insider | Meluzio Michael VincentVP, Prin. Accounting Officer | Sell (Open-market sale) | 1.14K sh | $32.09K | Read | ||||||
| Insider | Lin Shao-LeeChief Executive Officer | Sell (Open-market sale) | 11.09K sh | $305.49K | Read |
1W / 1M / 6M = how CUE moved from the trade or filing date.
Insider trading in CUE: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Ray Sumita | Chief Legal Compliance Officer | 1 | -$51.72K | Oct 12, 2026 | |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | 1 | -$32.09K | Oct 12, 2026 | |
| Lin Shao-Lee | Chief Executive Officer | 1 | -$305.49K | Oct 12, 2026 |
Frequently asked questions
Are CUE insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $389.30K, a net -$389.30K.
What is the latest insider trade in CUE?
Ray Sumita, Chief Legal Compliance Officer filed a sell (open-market sale) of 1.84K sh worth $51.72K on Oct 12, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.